MicroRNA and Posttranscriptional Dysregulation in Psychiatry
about
A momentary biomarker for depressive moodToward a Deeper Understanding of the Genetics of Bipolar DisorderDevelopmental suppression of schizophrenia-associated miR-137 alters sensorimotor function in zebrafish.miRNAs Plasma Profiles in Vascular Dementia: Biomolecular Data and Biomedical Implications.Reward Network Immediate Early Gene Expression in Mood DisordersAnimal models to improve our understanding and treatment of suicidal behaviorPrenatal exposure to valproic acid increases miR-132 levels in the mouse embryonic brainHypomethylation of miR-142 promoter and upregulation of microRNAs that target the oxytocin receptor gene in the autism prefrontal cortex.Whole-Genome Sequencing Suggests Schizophrenia Risk Mechanisms in Humans with 22q11.2 Deletion SyndromemiR-149 and miR-29c as candidates for bipolar disorder biomarkers.Post-transcriptional regulation of SHANK3 expression by microRNAs related to multiple neuropsychiatric disordersPediatric asthma and autism-genomic perspectives.Reciprocal Alterations in Regulator of G Protein Signaling 4 and microRNA16 in SchizophreniaExpression quantitative trait loci (eQTLs) in microRNA genes are enriched for schizophrenia and bipolar disorder association signals.TLX-Its Emerging Role for Neurogenesis in Health and Disease.Genetic variation in the miR-708 gene and its binding targets in bipolar disorder.Using hiPSCs to model neuropsychiatric copy number variations (CNVs) has potential to reveal underlying disease mechanisms.Epigenetic basis of sensitization to stress, affective episodes, and stimulants: implications for illness progression and prevention.Toward development of epigenetic drugs for central nervous system disorders: Modulating neuroplasticity via H3K4 methylation.MicroRNAs as biomarkers for psychiatric disorders with a focus on autism spectrum disorder: Current progress in genetic association studies, expression profiling, and translational research.Emerging role of miRNA in attention deficit hyperactivity disorder: a systematic review.Long noncoding RNA and its contribution to autism spectrum disorders.Preliminary evidence for association of genetic variants in pri-miR-34b/c and abnormal miR-34c expression with attention deficit and hyperactivity disorder.Knockdown of miR-155 protects microglia against LPS-induced inflammatory injury via targeting RACK1: a novel research for intracranial infection.MicroRNAs as biomarkers for major depression: a role for let-7b and let-7c.Large normal-range TBP and ATXN7 CAG repeat lengths are associated with increased lifetime risk of depression.Expression and Regulatory Network Analysis of miR-140-3p, a New Potential Serum Biomarker for Autism Spectrum Disorder.Treating the placenta to prevent adverse effects of gestational hypoxia on fetal brain development.Developmental excitatory-to-inhibitory GABA-polarity switch is disrupted in 22q11.2 deletion syndrome: a potential target for clinical therapeutics.Small RNAs May Answer Big Questions in Mental Illness.Therapeutic role of long non-coding RNA TCONS_00019174 in depressive disorders is dependent on Wnt/β-catenin signaling pathway.Preimplantation alcohol exposure and developmental programming of FASD: An epigenetic perspective.Noise-induced multistability in the regulation of cancer by genes and pseudogenes.Blood-Bourne MicroRNA Biomarker Evaluation in Attention-Deficit/Hyperactivity Disorder of Han Chinese Individuals: An Exploratory Study.A functional genetic variation of SLC6A2 repressor hsa-miR-579-3p upregulates sympathetic noradrenergic processes of fear and anxietyDual mechanisms for the regulation of brain-derived neurotrophic factor by valproic acid in neural progenitor cells
P2860
Q26765408-C84C1AE0-8AF6-4D98-B18A-DB4F44EEA1AFQ26797377-61D3D030-8FC3-4972-A552-50541CF35625Q30824416-76D6E4B6-D2BC-4135-AB78-6CA8194F8865Q31057893-4A5F69CC-D7A4-4BC2-B843-BC71B397F303Q33611438-C01B9032-C523-44D0-AAC9-D24D02FE23A1Q33635653-21BD7C40-4946-4E72-8E72-1E6ECAA2B87AQ33850875-D77D3B41-E8FA-4FF3-BCD8-2F5A05F99C41Q35949527-1EC19C47-7CA8-43CB-9A27-C7F554882375Q36245866-9E1987CC-CEEC-485A-A20A-5396DB10D74EQ36278042-AE4937E3-3EE9-4D7C-82C5-ECAC4CE7822DQ36286987-1C6C5EC7-F478-4676-B6FE-1E2B232068C8Q36369194-7A970730-F5B4-4262-BE66-71447C787F8AQ36580028-F2FB20F4-F56C-4772-8EAD-3E529BEABC95Q36837420-DA1ABDA7-76AF-4000-822C-381F450D325FQ37569901-11A28DF6-0AA4-4AF1-B9BC-48FA5AC1211FQ37593741-14E9797A-4DDF-4826-8A85-E94E83ADBEF1Q38637625-A61F04DA-6FC9-451B-9709-B7E80230F6C5Q38877779-CB9A84F9-4CFB-494B-970A-27F79E3A5D30Q38916715-F03E6D06-CD6D-4D33-ADD4-963CA85575B0Q39248707-88B27810-C288-489F-AF21-1071846CF4E8Q39298012-94AE021F-FDED-4B20-87CC-D0E39E40B66DQ39387599-9BEB1849-0100-470B-BE32-2CF167398791Q39439759-0F8AD773-9DAE-4CE0-8C37-29F2B34D9A96Q40095255-7F1B9DFD-0B42-434C-90E7-E5AC86BDD75CQ41084643-0A51263A-0968-44D6-92F6-2387103228FCQ41173141-869FAA0E-C625-4AB7-A485-BF91F0F5C2BDQ41369374-E09436BD-03F0-49EC-AA60-134A5590E0F9Q41489996-65FAF3FF-C311-4FA7-8301-E63124BF9B4FQ45738093-317464A9-8907-4E4F-B4C2-88C6321F61FCQ47112089-3ECB4186-182D-41D0-BC44-ECA56605BE41Q47610993-F32777AE-C4AE-4F27-82E3-B32DB1133E99Q50425298-8F94CBB8-F525-4D78-BDF0-CDE6C6B4960CQ50601740-5B8FA872-54E5-4658-A189-940481F93C05Q54985443-F2423178-26D6-4E07-A029-4B3BD829557FQ57811755-952EFF92-1A41-4102-BBFB-84A5BA4205AAQ58565218-4653484C-E59B-45B5-8C5A-2706155A3C63
P2860
MicroRNA and Posttranscriptional Dysregulation in Psychiatry
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
MicroRNA and Posttranscriptional Dysregulation in Psychiatry
@ast
MicroRNA and Posttranscriptional Dysregulation in Psychiatry
@en
MicroRNA and Posttranscriptional Dysregulation in Psychiatry
@nl
type
label
MicroRNA and Posttranscriptional Dysregulation in Psychiatry
@ast
MicroRNA and Posttranscriptional Dysregulation in Psychiatry
@en
MicroRNA and Posttranscriptional Dysregulation in Psychiatry
@nl
prefLabel
MicroRNA and Posttranscriptional Dysregulation in Psychiatry
@ast
MicroRNA and Posttranscriptional Dysregulation in Psychiatry
@en
MicroRNA and Posttranscriptional Dysregulation in Psychiatry
@nl
P3181
P1476
MicroRNA and Posttranscriptional Dysregulation in Psychiatry
@en
P2093
Michael Geaghan
P304
P3181
P356
10.1016/J.BIOPSYCH.2014.12.009
P407
P577
2014-12-18T00:00:00Z